Advertisement

Advertisement

HUMA Stock Latest News

Humacyte price target lowered to $1.25 from $1.50 at TD Cowen

The FlyHumacyte price target lowered to $1.25 from $1.50 at TD Cowen

Humacyte Announces Underwritten Public Equity Offering to Fund Growth

PremiumCompany Announcements

Humacyte Announces Underwritten Public Equity Offering to Fund Growth

28d ago

Humacyte price target raised to $4 from $3 at H.C. Wainwright

PremiumThe Fly

Humacyte price target raised to $4 from $3 at H.C. Wainwright

29d ago

Humacyte 47.62M share Spot Secondary priced at $1.05

PremiumThe Fly

Humacyte 47.62M share Spot Secondary priced at $1.05

29d ago

Humacyte TBA Spot Secondary; price range $1.05-$1.15

PremiumThe Fly

Humacyte TBA Spot Secondary; price range $1.05-$1.15

29d ago

Humacyte Announces Positive Phase 3 Dialysis Access Results

PremiumCompany AnnouncementsHumacyte Announces Positive Phase 3 Dialysis Access Results

29d ago

Humacyte announces V012 study of ATEV meets primary endpoint

The Fly

Humacyte announces V012 study of ATEV meets primary endpoint

29d ago

Humacyte announces common stock offering, no amount given

The Fly

Humacyte announces common stock offering, no amount given

29d ago

Humacyte Shareholders Approve Governance Changes and Share Increase

PremiumCompany Announcements

Humacyte Shareholders Approve Governance Changes and Share Increase

1M ago

Humacyte Regains Nasdaq Compliance With Minimum Bid Price

PremiumCompany Announcements

Humacyte Regains Nasdaq Compliance With Minimum Bid Price

1M ago

Largest borrow rate increases among liquid names

PremiumThe Fly

Largest borrow rate increases among liquid names

1M ago

Humacyte price target raised to $2 from $1 at Benchmark

PremiumThe Fly

Humacyte price target raised to $2 from $1 at Benchmark

1M ago

Humacyte announces presentation at VASA meeting on self-repair ATEV

PremiumThe FlyHumacyte announces presentation at VASA meeting on self-repair ATEV

1M ago

Largest borrow rate increases among liquid names

The Fly

Largest borrow rate increases among liquid names

2M ago

Humacyte reports Symvess under contract with Strategic Acquisition Center of VA

The Fly

Humacyte reports Symvess under contract with Strategic Acquisition Center of VA

2M ago

Humacyte price target raised to $1.50 from $1 at TD Cowen

PremiumThe Fly

Humacyte price target raised to $1.50 from $1 at TD Cowen

2M ago

Humacyte Earnings Call Balances Growth With Losses

PremiumCompany Announcements

Humacyte Earnings Call Balances Growth With Losses

2M ago

Humacyte: Buy Rating Reaffirmed as Jennings Lifts Price Target to $1.50 on Broad Growth Runway and Key Clinical Catalysts

PremiumRatings

Humacyte: Buy Rating Reaffirmed as Jennings Lifts Price Target to $1.50 on Broad Growth Runway and Key Clinical Catalysts

2M ago

Humacyte reports Q1 EPS (9c), consensus (12c)

PremiumThe Fly

Humacyte reports Q1 EPS (9c), consensus (12c)

2M ago

Humacyte names Todd Rasmussen chief surgical officer

PremiumThe FlyHumacyte names Todd Rasmussen chief surgical officer

2M ago

Humacyte Receives Nasdaq Notice on Minimum Bid Requirement

Company Announcements

Humacyte Receives Nasdaq Notice on Minimum Bid Requirement

2M ago

Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive

Class Action

Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >